top of page
Browse by category
Search
MHRA urges women using GLP-1s to use effective contraception
Medicines and Healthcare products Regulatory Agency (MHRA) urges women who are taking GLP-1 medicines for weight loss and diabetes - such...
Maternal obesity linked to child's heightened hospital admission risk for infection
Children who are born to mothers who are living with severe obesity (BMI of 35 or higher) are at heightened risk of being admitted to...
Combination of weight loss drugs better for pre-BMS patients than GLP-1s or dieting alone
A study by Pennington Biomedical Research Center's Metamor Institute researchers that evaluated the use of different types of pre-surgery...
COURAGE Trial confirms potential to improve the quality of semaglutide-induced weight loss by preserving lean mass
Interim results from the ongoing Phase 2 COURAGE trial - investigating novel combinations of semaglutide (GLP-1 receptor agonist) and...
Comorbid obesity and OSA treatment preferences found to differ among patients and providers
Sleep medicine professionals favour continuous positive airway pressure therapy as treatment for comorbid obesity and obstructive sleep...
Clinical advisory outlines eight key nutritional priorities to support patients on GLP-1 medications
Four leading organisations in lifestyle medicine, obesity medicine, and nutrition - the American College of Lifestyle Medicine (ACLM),...
Browse by tag
bottom of page